Biosante Pharmaceuticals shares owned by Ubs Global Asset Management Americas
Quarter-by-quarter ownership of Biosante Pharmaceuticals (ANIP) shares owned by Ubs Global Asset Management Americas
from 13F filings
Historical chart of Ubs Global Asset Management Americas investment in Biosante Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including Biosante Pharmaceuticals held by Ubs Global Asset Management Americas consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Biosante Pharmaceuticals by Ubs Global Asset Management Americas
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $2.7M | 30k | 91.61 |
| 2025-06-30 | $3.6M | 56k | 65.25 |
| 2025-03-31 | $3.2M | 48k | 66.95 |
| 2024-12-31 | $2.6M | 48k | 55.28 |
| 2024-09-30 | $2.0M | 34k | 59.66 |
| 2024-06-30 | $2.7M | 43k | 63.68 |
| 2024-03-31 | $1.1M | 16k | 69.13 |
| 2023-12-31 | $857k | 16k | 55.14 |
| 2023-09-30 | $902k | 16k | 58.06 |
| 2023-06-30 | $403k | 10k | 39.72 |
| 2023-03-31 | $403k | 10k | 39.72 |
| 2022-12-31 | $205k | 5.1k | 40.23 |
| 2022-09-30 | $208k | 6.5k | 32.14 |
| 2022-06-30 | $241k | 8.1k | 29.67 |
| 2022-03-31 | $214k | 7.6k | 28.11 |
| 2021-12-31 | $351k | 7.6k | 46.08 |
| 2021-09-30 | $250k | 7.6k | 32.82 |
| 2021-06-30 | $267k | 7.6k | 35.05 |
| 2021-03-31 | $245k | 6.8k | 36.14 |
| 2020-03-31 | $234k | 5.7k | 40.74 |
| 2019-12-31 | $371k | 6.0k | 61.67 |
| 2019-09-30 | $510k | 7.0k | 72.88 |
| 2019-06-30 | $448k | 5.4k | 82.20 |
| 2019-03-31 | $338k | 4.8k | 70.54 |
| 2018-12-31 | $38k | 842 | 45.02 |
| 2016-09-30 | $312k | 4.7k | 66.38 |
| 2016-06-30 | $246k | 4.4k | 55.91 |
| 2015-12-31 | $217k | 4.8k | 45.21 |
| 2015-06-30 | $273k | 4.4k | 62.05 |
More positions owned by Ubs Global Asset Management Americas
View all positions for Ubs Global Asset Management Americas